Table of Contents Author Guidelines Submit a Manuscript
Journal of Analytical Methods in Chemistry
Volume 2014, Article ID 241505, 12 pages
http://dx.doi.org/10.1155/2014/241505
Research Article

A Metabolomic Strategy to Screen the Prototype Components and Metabolites of Shuang-Huang-Lian Injection in Human Serum by Ultra Performance Liquid Chromatography Coupled with Quadrupole Time-of-Flight Mass Spectrometry

1Science Experiment Center for Traditional Chinese Medicine, Beijing University of Chinese Medicine, No. 11, North Third Ring Road, Chaoyang District, Beijing 100029, China
2School of Basic Medical Sciences, Beijing University of Chinese Medicine, No. 11, North Third Ring Road, Chaoyang District, Beijing 100029, China
3School of Chinese Material Medica, Beijing University of Chinese Medicine, South of Wangjing Middle Ring Road, Chaoyang District, Beijing, 100102, China

Received 22 December 2013; Accepted 19 January 2014; Published 26 February 2014

Academic Editor: Ying-Yong Zhao

Copyright © 2014 Mingxing Guo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Zhang, Q. Chen, W. Zhou et al., “Chinese medicine injection Shuanghuanglian for treatment of acute upper respiratory tract infection: a systematic review of randomized controlled trials,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 987326, 7 pages, 2013. View at Publisher · View at Google Scholar
  2. Y. Cao, L. Wang, X. Yu, and J. Ye, “Development of the chromatographic fingerprint of herbal preparations Shuang-Huang-Lian oral liquid,” Journal of Pharmaceutical and Biomedical Analysis, vol. 41, no. 3, pp. 845–856, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. The State Commission of Chinese Pharmacopoeia, Pharmacopoeia of People's Republic of China, part 1, Chemical Industry Press, Beijing, China, 2005.
  4. Y. M. Zhang, D. Yan, P. Zhang et al., “Quality control of Shuanghuanglian freeze-dried powder for injection based on its HPLC-ELSD fingerprints and biological profiles,” Acta Pharmaceutica Sinica, vol. 45, no. 1, pp. 93–97, 2010. View at Google Scholar · View at Scopus
  5. L. Liu, Z. Suo, and J. Zheng, “Simultaneous determination of four compounds in Sanjing Shuanghuanglian oral liquid by high performance liquid chromatography-diode array detection-electrochemical detection,” Chinese Journal of Chromatography, vol. 24, no. 3, pp. 247–250, 2006. View at Google Scholar · View at Scopus
  6. H. Cao and Y. Zhu, “Content determination of chlorogenic acid and baicalin in Shuanghuanglian oral solution by HPLC,” Drug Stands in China, vol. 8, no. 2, pp. 44–46, 2007. View at Google Scholar
  7. G. L. Yan, A. H. Zhang, H. Sun et al., “An effective method for determining the ingredients of Shuanghuanglian formula in blood samples using high-resolution LC-MS coupled with background subtraction and a multiple data processing approach,” Journal of Separation Science, vol. 36, no. 19, pp. 3191–3199, 2013. View at Google Scholar
  8. M. J. Zamek-Gliszczynski, K. A. Hoffmaster, K. I. Nezasa, M. N. Tallman, and K. L. R. Brouwer, “Integration of hepatic drug transporters and phase II metabolizing enzymes: mechanisms of hepatic excretion of sulfate, glucuronide, and glutathione metabolites,” European Journal of Pharmaceutical Sciences, vol. 27, no. 5, pp. 447–486, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Ishizuka, K. Konno, T. Shiina et al., “Species differences in the transport activity for organic anions across the bile canalicular membrane,” Journal of Pharmacology and Experimental Therapeutics, vol. 290, no. 3, pp. 1324–1330, 1999. View at Google Scholar · View at Scopus
  10. G. B. Scarfe, J. C. Lindon, J. K. Nicholson et al., “Investigation of the metabolism of 14C/13C-practolol in rat using directly coupled radio-HPLC-NMR-MS,” Xenobiotica, vol. 30, no. 7, pp. 717–729, 2000. View at Google Scholar · View at Scopus
  11. J. Iwabu, J. Watanabe, K. Hirakura, Y. Ozaki, and K. Hanazaki, “Profiling of the compounds absorbed in human plasma and urine after oral administration of a traditional Japanese (Kampo) medicine, daikenchuto,” Drug Metabolism and Disposition, vol. 38, no. 11, pp. 2040–2048, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. I. Iswaldi, D. Arráez-Román, A. M. Gómez-Caravaca et al., “Identification of polyphenols and their metabolites in human urine after cranberry-syrup consumption,” Food and Chemical Toxicology, vol. 55, pp. 484–492, 2013. View at Publisher · View at Google Scholar
  13. G. Tan, W. Liao, X. Dong et al., “Metabonomic profiles delineate the effect of traditional Chinese medicine Sini decoction on myocardial infarction in rats,” PLoS ONE, vol. 7, no. 4, Article ID e34157, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. O. Corcoran and M. Spraul, “LC-NMR-MS in drug discovery,” Drug Discovery Today, vol. 8, no. 14, pp. 624–631, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. M. S. Lee and E. H. Kerns, “LC/MS applications in drug development,” Mass Spectrometry Reviews, vol. 18, no. 3-4, pp. 187–279, 1999. View at Google Scholar · View at Scopus
  16. Y. Wu, “The use of liquid chromatography-mass spectrometry for the identification of drug degradation products in pharmaceutical formulations,” Biomedical Chromatography, vol. 14, no. 6, pp. 384–396, 2000. View at Google Scholar
  17. X. Wang, W. Sun, H. Sun et al., “Analysis of the constituents in the rat plasma after oral administration of Yin Chen Hao Tang by UPLC/Q-TOF-MS/MS,” Journal of Pharmaceutical and Biomedical Analysis, vol. 46, no. 3, pp. 477–490, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. S. L. Li, S. F. Lai, J. Z. Song et al., “Decocting-induced chemical transformations and global quality of Du-Shen-Tang, the decoction of ginseng evaluated by UPLC-Q-TOF-MS/MS based chemical profiling approach,” Journal of Pharmaceutical and Biomedical Analysis, vol. 53, no. 4, pp. 946–957, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Li, G. A. Luo, Q. L. Liang, P. Hu, and Y. M. Wang, “Rapid qualitative and quantitative analyses of Asian ginseng in adulterated American ginseng preparations by UPLC/Q-TOF-MS,” Journal of Pharmaceutical and Biomedical Analysis, vol. 52, no. 1, pp. 66–72, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Chen, F. J. Gonzalez, and J. R. Idle, “LC-MS-based metabolomics in drug metabolism,” Drug Metabolism Reviews, vol. 39, no. 2-3, pp. 581–597, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Y. Zhao, X. L. Cheng, F. Wei, X. Bai, and R. C. Lin, “Application of faecal metabonomics on an experimental model of tubulointerstitial fibrosis by ultra performance liquid chromatography/high-sensitivity mass spectrometry with MSE data collection technique,” Biomarkers, vol. 17, no. 8, pp. 7221–7729, 2012. View at Google Scholar
  22. P. D. Rainville, C. L. Stumpf, J. P. Shockcor, R. S. Plumb, and J. K. Nicholson, “Novel application of reversed-phase UPLC-oaTOF-MS for lipid analysis in complex biological mixtures: a new tool for lipidomics,” Journal of Proteome Research, vol. 6, no. 2, pp. 552–558, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Han, M. Ye, H. Guo, M. Yang, B. R. Wang, and D. A. Guo, “Analysis of multiple constituents in a Chinese herbal preparation Shuang-Huang-Lian oral liquid by HPLC-DAD-ESI-MSn,” Journal of Pharmaceutical and Biomedical Analysis, vol. 44, no. 2, pp. 430–438, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. Q. Z. Luo, J. B. Luo, and Y. Z. Wang, “Qualitative analysis of the main chemical constituents of Shuanghuanglian injection powder and their origin by HPLC-ESI/MS/MS spectrometry,” Acta Pharmaceutica Sinica, vol. 44, no. 12, pp. 1391–1396, 2009. View at Google Scholar · View at Scopus
  25. M. J. Zamek-Gliszczynski, K. A. Hoffmaster, K. I. Nezasa, M. N. Tallman, and K. L. R. Brouwer, “Integration of hepatic drug transporters and phase II metabolizing enzymes: mechanisms of hepatic excretion of sulfate, glucuronide, and glutathione metabolites,” European Journal of Pharmaceutical Sciences, vol. 27, no. 5, pp. 447–486, 2006. View at Publisher · View at Google Scholar · View at Scopus